Here's something that may actually be priced at free market value. Former hedge fund manager and Turing Pharmaceutical CEO Martin Shkreli is now auctioning off an opportunity to punch him in the face.
Here's something that may actually be priced at free market value. Former hedge fund manager and Turing Pharmaceutical CEO Martin Shkreli is now auctioning off an opportunity to punch him in the face.
Share this Article
Comment on this Article
Recommended
Please to comment